Functional Connectivity Alterations and Molecular Characterization of the Anterior Cingulate Cortex in Tinnitus Pathology without Hearing Loss
Source abstract
Abstract
Abstract Compared with individuals with hearing loss, tinnitus patients without hearing loss have more psychological or emotional problems. Tinnitus is closely associated to abnormal metabolism and function of the limbic system, a key brain region for emotion experience, but the underlying molecular mechanism remains unknown. Using whole‐brain microvasculature dynamics imaging, the anterior cingulate cortex (ACC) is identified as a key brain region of limbic system involve in the onset of salicylate‐induced tinnitus in mice. In the tinnitus group, there is enhanced purine metabolism, oxidative phosphorylation, and a distinct pattern of phosphorylation in glutamatergic synaptic pathway according to the metabolome profiles, quantitative proteomic, and phosphoproteomic data of mice ACC tissue. Electroencephalogram in tinnitus patients with normal hearing thresholds show that the functional connectivity between pregenual anterior cingulate cortex and the primary auditory cortex is significantly increased for high‐gamma frequency band, which is positively correlated with the serum glutamate level. These findings indicate that ACC plays an important role in the pathophysiology of tinnitus by interacting with the primary auditory cortex and provide potential molecular targets in the ACC for tinnitus treatment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hearing, Cochlea, Tinnitus, Genetics · Biochemical Analysis and Sensing Techniques · Neural dynamics and brain function
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
ENT Institute and Department of Otorhinolaryngology EYE & ENT Hospital Fudan University Shanghai 200031 China
NHC Key Laboratory of Hearing Medicine Fudan University Shanghai 200031 China
Clinical Laboratory Center Children's Hospital of Fudan University Shanghai 201102 China
Zhejiang Chinese Medical University Hangzhou Zhejiang 310053 China
Funding
National Natural Science Foundation of China
References (50)
Show source-provided references
1. 10.1016/S0140-6736(13)60142-710.1016/S0140-6736(13)60142-7 ↗
2. 10.1001/jamaneurol.2022.218910.1001/jamaneurol.2022.2189 ↗
3. 10.5152/iao.2019.625710.5152/iao.2019.6257 ↗
4. 10.1002/lary.2610710.1002/lary.26107 ↗
5. 10.1136/bmjopen-2015-01059610.1136/bmjopen-2015-010596 ↗
6. 10.1016/j.ijporl.2016.07.03610.1016/j.ijporl.2016.07.036 ↗
7. 10.3390/medicina5702011410.3390/medicina57020114 ↗
8. 10.1177/000348941560644510.1177/0003489415606445 ↗
9. 10.1016/j.neuron.2010.04.03210.1016/j.neuron.2010.04.032 ↗
10. 10.3389/fnins.2020.0059110.3389/fnins.2020.00591 ↗
11. 10.1097/MAO.000000000000318310.1097/MAO.0000000000003183 ↗
12. 10.7554/eLife.0657610.7554/eLife.06576 ↗
13. 10.1016/j.neuron.2010.12.00210.1016/j.neuron.2010.12.002 ↗
14. 10.1016/S0301-0082(00)00027-710.1016/S0301-0082(00)00027-7 ↗
15. 10.1007/s00359-019-01339-z10.1007/s00359-019-01339-z ↗
16. 10.1007/s12640-019-0006-810.1007/s12640-019-0006-8 ↗
17. 10.1016/j.heares.2015.10.00810.1016/j.heares.2015.10.008 ↗
18. 10.1073/pnas.84.5.141710.1073/pnas.84.5.1417 ↗
19. 10.1038/s41592-019-0572-y10.1038/s41592-019-0572-y ↗
20. 10.1038/nature2061210.1038/nature20612 ↗
21. 10.1038/s41591-020-0815-610.1038/s41591-020-0815-6 ↗
22. 10.1016/j.neuron.2020.11.00210.1016/j.neuron.2020.11.002 ↗
23. 10.3390/biomedicines1005110710.3390/biomedicines10051107 ↗
24. 10.1001/jamaoto.2023.005210.1001/jamaoto.2023.0052 ↗
25. 10.1007/s12070-023-03600-z10.1007/s12070-023-03600-z ↗
26. 10.1016/j.cell.2010.12.00110.1016/j.cell.2010.12.001 ↗
27. 10.1002/hbm.2523810.1002/hbm.25238 ↗
28. 10.1016/j.cell.2006.09.02610.1016/j.cell.2006.09.026 ↗
29. 10.1523/JNEUROSCI.0551-15.201510.1523/JNEUROSCI.0551-15.2015 ↗
30. 10.1007/7854_2020_15610.1007/7854_2020_156 ↗
31. 10.1044/2020_AJA-20-0002310.1044/2020_AJA-20-00023 ↗
32. 10.1523/JNEUROSCI.0026-12.201210.1523/JNEUROSCI.0026-12.2012 ↗
33. 10.1074/jbc.M30923220010.1074/jbc.M309232200 ↗
34. 10.1016/j.canlet.2020.07.02710.1016/j.canlet.2020.07.027 ↗
35. 10.1016/S0197-4580(00)00112-310.1016/S0197-4580(00)00112-3 ↗
36. 10.3390/biomedicines911158710.3390/biomedicines9111587 ↗
37. 10.3389/fnsys.2012.0000910.3389/fnsys.2012.00009 ↗
38. 10.1016/j.heares.2019.01.02110.1016/j.heares.2019.01.021 ↗
39. 10.1038/338334a010.1038/338334a0 ↗
40. 10.1016/S0896-6273(00)80821-110.1016/S0896-6273(00)80821-1 ↗
41. 10.3389/fnhum.2013.0059510.3389/fnhum.2013.00595 ↗
42. 10.3389/fnins.2018.0000910.3389/fnins.2018.00009 ↗
43. 10.1016/j.heares.2015.08.00510.1016/j.heares.2015.08.005 ↗
44. 10.1016/j.jneumeth.2021.10913910.1016/j.jneumeth.2021.109139 ↗
45. 10.1016/S0169-328X(00)00194-710.1016/S0169-328X(00)00194-7 ↗
46. 10.1021/acsami.0c1940010.1021/acsami.0c19400 ↗
47. 10.1016/j.dcn.2019.10068710.1016/j.dcn.2019.100687 ↗
48. Pascual‐Marqui R. D. · Methods Find. Exp. Clin. Pharmacol. · 2002 · 24 · 5
49. 10.1016/S1388-2457(02)00030-510.1016/S1388-2457(02)00030-5 ↗
50. Pascual‐Marqui R. D. · arXiv. · 2007 · 11 · 1455